Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a Minnesota-based medical device company specializing in totally implantable hearing technology, including its flagship Acclaim Totally Implantable Cochlear Implant. The company entered public markets in 2023 through a SPAC business combination, with its September 2023 Form 8-K filing reflecting material disclosures in the period surrounding that transaction close. Envoy Medical operates within the medical devices and audiological health sector, addressing severe-to-profound hearing loss with fully implanted, external-component-free solutions. As a newly public company navigating post-merger reporting obligations, COCH represents the type of development-stage medtech issuer that SPAC investors have closely tracked in recent years. For complete filing history, deal structure data, and sponsor intelligence on COCH and every active and completed SPAC transaction, sign up for full access at SpacDesk.